A 42-year-old man with dilated cardiomyopathy and endstage heart failure was evaluated for heart transplantation. He received a MitraClip and Carillon annuloplasty device for functional mitral regurgitation as palliation for his heart failure. Subsequently, he underwent successful heart transplantation.
GarattiACastelvecchioSBanderaFMeddaMMenicantiL. MitraClip procedure as a bridge therapy in a patient with heart failure listed for heart transplantation. Ann Thorac Surg2015; 99: 1796–1799.
2.
MaisanoFFranzenOBaldusSet al.Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol2013; 62: 1052–1061.
3.
SiminiakTWuJCHaudeMet al.Treatment of functional mitral regurgitation by percutaneous annuloplasty: results of the TITAN trial. Eur J Heart Fail2012; 14: 931–938.
4.
WhitlowPLFeldmanTPedersenWRet al.Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. J Am Coll Cardiol2012; 59: 130–139.
5.
SchoferJSiminiakTHaudeMet al.Percutaneous mitral annuloplasty for functional mitral regurgitation results of the CARILLON Mitral Annuloplasty Device European Union Study. Circulation2009; 120: 326–333.
